73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Palliative care in breast cancer treatment may be less likely for racial/ethnic minority patients than white patients

Palliative care in breast cancer treatment may be less likely for racial/ethnic minority patients than white patients

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainDespite a steady increase in palliative care utilization from 2004 to 2020, non-Hispanic Black, Hispanic, and Asian or

Palliative care in breast cancer treatment may be less likely for racial/ethnic minority patients than white patients

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainDespite a steady increase in palliative care utilization from 2004 to 2020, non-Hispanic Black, Hispanic, and Asian or
New reports examine COVID's radiotherapy interruption implications

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur
Active surveillance feasible for small, low-grade bladder cancer

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F
Researchers find capsules surrounding liver metastases of colorectal cancer are a healing response by the liver

Researchers find capsules surrounding liver metastases of colorectal cancer are a healing response by the liver

by Karolinska InstitutetFluorescent protein stains of tumor growing in the liver. Credit: Marco Gerling, Carina StrellA study by researchers from Karolinska Institutet and physicians from Karolin

Researchers find capsules surrounding liver metastases of colorectal cancer are a healing response by the liver

by Karolinska InstitutetFluorescent protein stains of tumor growing in the liver. Credit: Marco Gerling, Carina StrellA study by researchers from Karolinska Institutet and physicians from Karolin
Scientist identifies gene responsible for spread of prostate cancer

Scientist identifies gene responsible for spread of prostate cancer

by Caitlin Coyle,Rutgers UniversityAntonina Mitrofanova is a pioneer in the emerging field of biomedical informatics, fighting cancer with big data. Credit: Nick RomanenkoA Rutgers study has fou

Scientist identifies gene responsible for spread of prostate cancer

by Caitlin Coyle,Rutgers UniversityAntonina Mitrofanova is a pioneer in the emerging field of biomedical informatics, fighting cancer with big data. Credit: Nick RomanenkoA Rutgers study has fou
Precision oncology insights revealed for colorectal cancer

Precision oncology insights revealed for colorectal cancer

by UNC Lineberger Comprehensive Cancer CenterCredit: CC0 Public DomainNext-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to

Precision oncology insights revealed for colorectal cancer

by UNC Lineberger Comprehensive Cancer CenterCredit: CC0 Public DomainNext-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to
Few with CRC in sub-Saharan Africa receive guideline-concordant care

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September
Metachronous pathology assessed in young-onset colorectal cancer survivors

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published
Children of parents with cancer history in US may be vulnerable to housing, food and financial hardship

Children of parents with cancer history in US may be vulnerable to housing, food and financial hardship

by American Cancer SocietyCredit: Pixabay/CC0 Public DomainA new study by researchers at the American Cancer Society (ACS) found children of parents with a cancer history in the United States are

Children of parents with cancer history in US may be vulnerable to housing, food and financial hardship

by American Cancer SocietyCredit: Pixabay/CC0 Public DomainA new study by researchers at the American Cancer Society (ACS) found children of parents with a cancer history in the United States are
Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

by Lori SolomonOutcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly improved over t

Allogeneic hematopoietic cell transplant outcomes improved from 2005 to 2019: Study

by Lori SolomonOutcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly improved over t
New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit

New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit
Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers

Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers

by Dana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.09.005Loss of the "housekeeping" gene methylthioadenosine phosphorylas

Study offers way to increase immune checkpoint inhibitor effectiveness in patients with MTAP-deleted cancers

by Dana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.09.005Loss of the "housekeeping" gene methylthioadenosine phosphorylas